S.A. Mason’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $489K | Hold |
4,040
| – | – | 0.24% | 97 |
|
|
2025
Q1 | $450K | Hold |
4,040
| – | – | 0.24% | 101 |
|
|
2024
Q4 | $393K | Hold |
4,040
| – | – | 0.21% | 114 |
|
|
2024
Q3 | $465K | Hold |
4,040
| – | – | 0.25% | 97 |
|
|
2024
Q2 | $430K | Hold |
4,040
| – | – | 0.24% | 96 |
|
|
2024
Q1 | $391K | Sell |
4,040
-200
| -5% | -$19.3K | 0.23% | 106 |
|
|
2023
Q4 | $428K | Hold |
4,240
| – | – | 0.29% | 96 |
|
|
2023
Q3 | $432K | Hold |
4,240
| – | – | 0.31% | 87 |
|
|
2023
Q2 | $390K | Hold |
4,240
| – | – | 0.28% | 97 |
|
|
2023
Q1 | $390K | Buy |
4,240
+104
| +3% | +$9.57K | 0.28% | 97 |
|
|
2022
Q4 | $375K | Hold |
4,136
| – | – | 0.28% | 97 |
|
|
2022
Q3 | $314K | Hold |
4,136
| – | – | 0.25% | 110 |
|
|
2022
Q2 | $350K | Hold |
4,136
| – | – | 0.26% | 105 |
|
|
2022
Q1 | $363K | Hold |
4,136
| – | – | 0.23% | 117 |
|
|
2021
Q4 | $362K | Hold |
4,136
| – | – | 0.22% | 114 |
|
|
2021
Q3 | $338K | Buy |
4,136
+450
| +12% | +$36.8K | 0.22% | 119 |
|
|
2021
Q2 | $336K | Hold |
3,686
| – | – | 0.23% | 118 |
|
|
2021
Q1 | $315K | Hold |
3,686
| – | – | 0.24% | 115 |
|
|
2020
Q4 | $348K | Hold |
3,686
| – | – | 0.29% | 94 |
|
|
2020
Q3 | $321K | Sell |
3,686
-8
| -0.2% | -$697 | 0.31% | 93 |
|
|
2020
Q2 | $323K | Hold |
3,694
| – | – | 0.34% | 85 |
|
|
2020
Q1 | $305K | Sell |
3,694
-132
| -3% | -$10.9K | 0.37% | 77 |
|
|
2019
Q4 | $362K | Buy |
+3,826
| New | +$362K | 0.35% | 85 |
|